Future-Ready: Liposomal Doxorubicin Market Set for Transformative Developments by 2034 The Liposomal Doxorubicin Market is gaining significant attention as oncology treatment paradigms shift toward more targeted, efficient, and safer drug delivery systems. Liposomal doxorubicin, an advanced formulation of the traditional chemotherapy drug doxorubicin, encapsulates the active compound within liposomes lipid-based vesicles that improve circulation time and reduce systemic toxicity....